The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Nanoparticles for drug delivery to the anterior segment of the eye
Open accessAbstract
Commercially available ocular drug delivery systems are effective but less efficacious to manage diseases/disorders of the anterior segment of the eye. Recent advances in nanotechnology and molecular biology offer a great opportunity for efficacious ocular drug delivery for the treatments of anterior segment diseases/disorders. Nanoparticles have been designed for preparing eye drops or injectable solutions to surmount ocular obstacles faced after administration. Better drug pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, and biorecognition can be achieved to improve drug efficacy when drugs are loaded in the nanoparticles. Despite the fact that a number of review articles have been published at various points in the past regarding nanoparticles for drug delivery, there is not a review yet focusing on the development of nanoparticles for ocular drug delivery to the anterior segment of the eye. This review fills in the gap and summarizes the development of nanoparticles as drug carriers for improving the penetration and bioavailability of drugs to the anterior segment of the eye.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–214 of 214
Study of ocular drug delivery system using drug-loaded liposomes
Jain, R., & Shastri, J. (2011) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.76727 · Cited by 50
Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application
Yoncheva, K., Vandervoort, J., & Ludwig, A. (2009) · Pharmaceutical Development and Technology · doi:10.3109/10837450903479954 · Cited by 48
Diepold, R., Kreuter, J., Guggenbuhl, P., & Robinson, J. R. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90334-7 · Cited by 48
Zhang, W., Zu, D., Chen, J., Peng, J., Liu, Y., Zhang, H., Li, S., & Pan, W. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.043 · Cited by 36
Novel Topical Ophthalmic Formulations for Management of Glaucoma
Ibrahim, M. M., Abd-Elgawad, A.-E. H., Soliman, O. A. E.-A., & Jablonski, M. M. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1109-1 · Cited by 35
Suresh, P. K., & Sah, A. K. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.938045 · Cited by 34
Horvát, G., Budai-Szűcs, M., Berkó, S., Szabó‐Révész, P., Soós, J., Facskó, A., Maroda, M., Mori, M., Sandri, G., Bonferoni, M. C., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.024 · Cited by 31
Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.
Najlah, M., & D’Emanuele, A. (2007) · PubMed · Cited by 29
Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor
Sharma, A. K., Sahoo, P. K., MAJUMDAR, D. K., Sharma, N., Sharma, R. K., & Kumar, A. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1183720 · Cited by 29
Ibrahim, M. M., Abd-Elgawad, A.-E. H., Soliman, O. A.-E., & Jablonski, M. M. (2013) · journal of Pharmaceutical Technology and Drug Research · doi:10.7243/2050-120x-2-7 · Cited by 28
Tártara, L. I., Quinteros, D. A., Saino, V., Allemandi, D. A., & Palma, S. D. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0104 · Cited by 27
Nemoto, E., UEDA, H. M. D., Akimoto, M., Natsume, H., & Morimoto, Y. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1768 · Cited by 26
Ocular Drug Delivery Systems : Barriers and Application of Nanoparticulate Systems
Thassu, D., & Chader, G. J. (2012) · CRC Press eBooks · Cited by 24
Liu, R., Wang, S., Sun, L., Fang, S., Wang, J., Huang, X., You, Z., He, X., & Liu, C. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.03.009 · Cited by 23
Cited by
Bachu, R., Chowdhury, P., Al-Saedi, Z., Karla, P., & Boddu, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010028 · Cited by 421
Samuel, M. S., Ravikumar, M., John J., A., Selvarajan, E., Patel, H., Chander, P. S., Soundarya, J., Vuppala, S., Balaji, R., & Chandrasekar, N. (2022) · Catalysts · doi:10.3390/catal12050459 · Cited by 419
Advances and limitations of drug delivery systems formulated as eye drops
Jumelle, C., Gholizadeh, S., Annabi, N., & Dana, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.057 · Cited by 408
Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114770 · Cited by 322
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 277
Metadata
- Authors
- Janagam, D. R., Wu, L., & Lowe, T. L.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 122
- Pages
- 31-64
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2604905682
- Cited by
- 341
- References
- 214
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.